ArticleOncoimmunology
FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy.
Beata Pyrzynska et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
cites it
ArticleOncoimmunology
Beata Pyrzynska et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.